BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Genekam Biotechnology AG Release: First Worldwide Commercial DNA Test For H5N1 And H9 To Detect Avian Influenza Virus


11/29/2005 12:44:32 PM

DUISBURG, Germany, November 29 /PRNewswire-FirstCall/ -- German's molecular medicine company Genekam did a good job on developing a most reliable and accurate DNA-based test that is able to detect the avian influenza virus H5N1 along with the not less dangerous H9 virus in a very short time. It can be performed under field conditions. Till today such tests were not available on the market.

Already again, newspapers said early this week, that a 9 year old boy laid up with an avian influenza infection for the first time in China. Chinese's government did not yet confirm whether it is the dangerous virus known as bird flu. The only reason is that the authorities used tests based on antibodies called serological or rapid-test. But all these serological tests are inaccurate and may lead to cross reactions, hence may give false positive and leading to false alarms. The verification of this case is usually done through a special laboratory, which needs many days to confirm the results i.e. A waste of precious time that would have better been used for preventive measures.

With Genekam's latest developed test the result is available within seven hours, which are most precise and accurate. Moreover this DNA-test is not only available for special labs but may also be performed by the smallest laboratories throughout the world for a reasonable price. The recognition of the avian influenza virus in China would have been possible in an earlier stage using Genekam's bird flu test. Similarly such false alarm raised through Greece would have been avoided, if the Greece laboratories would have used the Genekam DNA tests.

This particular test is based on the PCR-method (polymerase chain reaction). It can be used to detect a latent and symptomless infection (e.g. migratory birds) in human as well as animals, so preventive measures can be ordered immediately. The serological or rapid tests are not able to detect such symptomless carries. Earlier detection can be also only through DNA test. More earlier you detect the case, more earlier, one can start with the preventive measurement.

Genekam Biotechnology AG, developing and distributing about 120 DNA tests so far, is at present engaged in researching to develop a test for detecting the virus H7.

e-mail: query@genekam.de Website: www.genekam.de Genekam Biotechnology AG Dammstrasse 31 - 33 47119 Duisburg Germany Tel: +49-203-55-58-58-31 Fax: +49-203-35-82-99 Internet: www.genekam.de e-mail: query@genekam.de

Genekam Biotechnology AG

CONTACT: Genekam Biotechnology AG, Tel: +49-203-55-58-58-31, Fax:+49-203-35-82-99, e-mail: query@genekam.de



Read at BioSpace.com

   
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES